Copyright 2009 Medical News Today Latest COPD News From Medical News Today. http://www.medicalnewstoday.com/sections/copd/ admin@medicalnewstoday.com (MNT Admin) editors@medicalnewstoday.com (MNT Editors) en-us Fri, 20 Nov 2009 18:00:00 PST http://www.medicalnewstoday.com/articles/171710.php http://www.medicalnewstoday.com/articles/171710.php The U.S. Food and Drug Administration (FDA) Pulmonary-Allergy Drugs Advisory Committee voted 11 to 1 that clinical data included in a supplemental new drug application (sNDA) provide substantial and convincing evidence to support the claim that SPIRIVA® HandiHaler® (tiotropium bromide inhalation powder) reduces exacerbations (worsening of symptoms) in patients with chronic obstructive pulmonary disease (COPD). COPD Fri, 20 Nov 2009 01:00:00 PST http://www.medicalnewstoday.com/articles/171579.php http://www.medicalnewstoday.com/articles/171579.php The European Federation of Allergy and Airways Diseases Patients Associations (EFA) today launched a book comparing and analysing the situation of Chronic Obstructive Pulmonary Disease (COPD) in Europe for the first time from the patients' perspective. The Book highlights and urgent need to reduce the suffering and mortality from this disease, which will - if not tackled appropriately - be the third leading cause of death worldwide by 2030. COPD Wed, 18 Nov 2009 07:00:00 PST http://www.medicalnewstoday.com/articles/171352.php http://www.medicalnewstoday.com/articles/171352.php Broncus Technologies, Inc., a medical technology company focused on developing and commercializing innovative solutions for lung diseases, is announcing early results of the EASE (Exhale Airway Stents for Emphysema) Trial, the first ever, double-blinded, randomized, sham-controlled device study for patients with emphysema/COPD. COPD Wed, 11 Nov 2009 03:00:00 PST http://www.medicalnewstoday.com/articles/170544.php http://www.medicalnewstoday.com/articles/170544.php Celebrated comedian and actress Mary Walsh is using her voice to raise awareness about Chronic Obstructive Pulmonary Disease (COPD) for this year's World COPD campaign. Walsh is best known for her work on the acclaimed TV show This Hour Has 22 Minutes, especially her character, Marg Delahunty, a sword-wielding warrior princess who cornered Canadian politicians on camera. "Many people know the lighter side of Mary, but COPD is something she is very serious about. COPD Thu, 05 Nov 2009 13:00:00 PST http://www.medicalnewstoday.com/articles/169982.php http://www.medicalnewstoday.com/articles/169982.php New study results showed that 42.3 percent of smokers with mild-to-moderate chronic obstructive pulmonary disease (COPD) who took CHANTIX/CHAMPIX® (varenicline) were able to quit smoking and remain abstinent during the last four weeks of treatment (weeks 9-12) compared with 8.8 percent of those given placebo (p Smoking / Quit Smoking Thu, 05 Nov 2009 04:00:00 PST http://www.medicalnewstoday.com/articles/169944.php http://www.medicalnewstoday.com/articles/169944.php New Formula Calculates More Accurate 'Lung Age' in Smokers (#7896 ) A new formula more accurately calculates a smoker's "lung age," which researchers hope will help persuade patients to quit the habit. A research team from Biomedical Research Institute at Harbor-UCLA Medical Center, Los Angeles, CA, developed and evaluated a new lung age formula based on %FEV1/FEV6 rather than the current lung age formulas based on height and FEV1 or FVC. Smoking / Quit Smoking Thu, 05 Nov 2009 04:00:00 PST http://www.medicalnewstoday.com/articles/169948.php http://www.medicalnewstoday.com/articles/169948.php Air Pollution Major Factor in Fresno Health (#8164) Air pollution is a major health risk for patients in Fresno, CA, who suffer from chronic lung diseases. Researchers from the University of California, San Francisco, Fresno compared the weekly rates of those admitted to the ER with asthma or chronic obstructive pulmonary disease (COPD) with air pollution indices for corresponding weeks. Respiratory / Asthma Tue, 03 Nov 2009 05:00:00 PST http://www.medicalnewstoday.com/articles/169651.php http://www.medicalnewstoday.com/articles/169651.php Awareness of COPD - chronic obstructive pulmonary disease - continues to grow in the United States, according to national survey results released by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health. Sixty-eight percent of adults are now aware of COPD, a disease that affects 1 in 5 people over age 45, compared with 64 percent last year, and 49 percent in a 2004 survey. COPD Fri, 30 Oct 2009 03:00:00 PST http://www.medicalnewstoday.com/articles/169273.php http://www.medicalnewstoday.com/articles/169273.php Tropical zebrafish have helped researchers at the University of Sheffield pave the way for the discovery of new anti-inflammatory drugs to treat illnesses such as chronic obstructive pulmonary disease (COPD) and asthma. COPD Tue, 13 Oct 2009 03:00:00 PST http://www.medicalnewstoday.com/articles/167158.php http://www.medicalnewstoday.com/articles/167158.php Bio-Matrix Scientific Group, Inc. (OTCBB: BMSN) provided a progress report on the Company's previously announced new opportunities. The Company has been moving forward in the areas of stem cell research for treatment of Chronic Obstructive Pulmonary Disease (COPD), Tumor Banking and Cancer Treatment. COPD Tue, 13 Oct 2009 02:00:00 PST http://www.medicalnewstoday.com/articles/167142.php http://www.medicalnewstoday.com/articles/167142.php The Lung Association invites you to register now for the Coast 2 Coast Challenge, a virtual trek across Canada to raise awareness of COPD, a long-term breathing disease. Registration is free for this exciting event, which will start November 1st and go until November 18th, World COPD Day. Everyone is welcome to take part. If you or someone you love has COPD, or if you're interested in supporting this great cause, please join us. Here's how it works: 1. COPD Fri, 09 Oct 2009 01:00:00 PST http://www.medicalnewstoday.com/articles/166761.php http://www.medicalnewstoday.com/articles/166761.php National Jewish Health and four other research centers have been awarded an $11 million, two-year grant from the National Heart Lung and Blood Institute as part of the NIH Recovery Act that will allow a team of national scientists to delve deeply into the biology of two fatal lung diseases for which there are few therapeutic options. COPD Thu, 08 Oct 2009 19:00:00 PST http://www.medicalnewstoday.com/articles/166713.php http://www.medicalnewstoday.com/articles/166713.php Patients with moderate to severe chronic obstructive pulmonary disease (COPD) can benefit from triple therapy that includes a long-acting β-agonist (LABA), an inhaled corticosteroid (ICS) and an anti-muscarinic agent, according to researchers in Germany. COPD Thu, 08 Oct 2009 01:00:00 PST http://www.medicalnewstoday.com/articles/166595.php http://www.medicalnewstoday.com/articles/166595.php VENTILATION MASK LEAKAGE MAY CONTAMINATE HOSPITAL ROOM New research shows that certain noninvasive positive pressure ventilation (NPPV) masks may leak exhaled air up to a distance of 1 m from patients receiving treatments. This finding raises concerns about the potential spread of highly contagious respiratory illness within the hospital setting. Infectious Diseases / Bacteria / Viruses Mon, 21 Sep 2009 01:00:00 PST http://www.medicalnewstoday.com/articles/164586.php http://www.medicalnewstoday.com/articles/164586.php In the air, it is a serious pollutant. In the body, it plays a role in heart rate, blood flow, nerve signals and immune function. Nitric oxide, a gas well known to scientists for its myriad functions, has proven challenging to measure accurately outside the laboratory. A team of Princeton and Rice University researchers has demonstrated a new method of identifying the gas using lasers and sensors that are inexpensive, compact and highly sensitive. Medical Devices / Diagnostics Thu, 17 Sep 2009 00:00:00 PST http://www.medicalnewstoday.com/articles/164160.php http://www.medicalnewstoday.com/articles/164160.php In the lung, mucus is produced by cells known as goblet cells, which are present in small numbers in the walls of the lungs and airways. Many inflammatory stimuli, including allergens, cigarette smoke, and chronic infections, increase the number and activity of these goblet cells. COPD Wed, 16 Sep 2009 04:00:00 PST http://www.medicalnewstoday.com/articles/164118.php http://www.medicalnewstoday.com/articles/164118.php In a development that could lead to a novel approach to the treatment of a devastating lung disease, biochemists at The University of Texas Health Science Center at Houston report they are the first to link the osteopontin (OPN) protein to chronic obstructive pulmonary disease (COPD). Findings appear online and will be in the January 2010 print issue of The FASEB Journal, the journal of The Federation of American Societies for Experimental Biology. COPD Thu, 10 Sep 2009 00:00:00 PST http://www.medicalnewstoday.com/articles/163393.php http://www.medicalnewstoday.com/articles/163393.php Almirall, S.A. (ALM.MC) today announced its intention to file a Marketing Authorization Application (MAA) with the European Medicines Agency (EMEA) for its once-daily long acting muscarinic antagonist Eklira® (aclidinium bromide) in early 2010, for the maintenance bronchodilator treatment and symptom control of COPD. COPD is an under-diagnosed progressive lung disease which causes difficulties with breathing, deterioration in the quality of life and it may lead to death. COPD Wed, 09 Sep 2009 02:00:00 PST http://www.medicalnewstoday.com/articles/163308.php http://www.medicalnewstoday.com/articles/163308.php The Lung Association released the following statement with regards to their campaign to ban pets on board airplanes: "Since July 2009, thousands of Canadians from across the country have joined our campaign to ensure pet-free flights from Canada's major airlines. While Air Canada and WestJet continue to be uninterested in protecting the health of those with Respiratory / Asthma Tue, 08 Sep 2009 03:00:00 PST http://www.medicalnewstoday.com/articles/163224.php http://www.medicalnewstoday.com/articles/163224.php A new vaccine against pneumonia may offer better protection from chronic obstructive pulmonary disease (COPD) patients than the currently accepted vaccine, according to recent research that will be published in the September 15 issue of the American Journal of the Respiratory and Critical Care Journal, a publication of the American Thoracic Society. COPD Tue, 08 Sep 2009 03:00:00 PST http://www.medicalnewstoday.com/articles/163239.php http://www.medicalnewstoday.com/articles/163239.php PEDIATRIC CHRONIC COUGH LINKED TO REFLUX AND ALLERGIES New research shows that chronic cough in children is most often caused by gastroesophageal reflux and allergies. Researchers from Tulane University in New Orleans, LA, evaluated 40 patients aged 5 to 12 years with chronic cough (> 8 weeks in duration) with no obvious cause. Each patient underwent extensive multispecialty testing. Respiratory / Asthma Mon, 07 Sep 2009 02:00:00 PST http://www.medicalnewstoday.com/articles/163138.php http://www.medicalnewstoday.com/articles/163138.php Pharmacists are being urged to identify and refer patients with chronic lung and other conditions who have problems with their medication, following research showing that two thirds of asthma and COPD patients are under-using preventer inhalers and risking unnecessary breathing problems. Respiratory / Asthma Sun, 06 Sep 2009 00:00:00 PST http://www.medicalnewstoday.com/articles/163061.php http://www.medicalnewstoday.com/articles/163061.php COPD is an under-diagnosed progressive lung disease that may lead to death. In Canada, approximately 500,000 people over the age of 35 have been diagnosed with COPD, and it is estimated that an almost equal number of middle-aged Canadians may also have COPD, but are not aware of it.i In fact, by 2020, it is estimated that COPD will be the third leading cause of death worldwide.ii Roflumilast, a once-a-day oral tablet, would be the first in a new class of treatment for COPD. COPD Tue, 01 Sep 2009 00:00:00 PST http://www.medicalnewstoday.com/articles/162351.php http://www.medicalnewstoday.com/articles/162351.php Researchers have developed an index scale to help physicians predict a patient's risk of dying from chronic obstructive pulmonary disease (COPD). The ADO index can help physicians assess the severity of a patient's illness to determine the appropriate level of treatment. COPD, which comprises emphysema and chronic bronchitis, is a major public health problem and it is the fourth leading cause of death in the U.S. COPD Mon, 31 Aug 2009 01:00:00 PST http://www.medicalnewstoday.com/articles/162276.php http://www.medicalnewstoday.com/articles/162276.php Roflumilast, an oral, once a day anti-inflammatory agent, improves lung function and reduces exacerbations in patients with chronic obstructive pulmonary disease (COPD) who have chronic respiratory symptoms and are at greater risk of exacerbations. The effect persists even when roflumilast is added to conventional treatment with inhaled long-acting bronchodilators. Thus, roflumilast therapy has the potential to become an important treatment for these patients. COPD